These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7858 related articles for article (PubMed ID: 1631220)

  • 1. Prevention of microvascular thrombosis with low-dose tissue plasminogen activator.
    Arnljots B; Wieslander JB; Dougan P; Salemark L
    Plast Reconstr Surg; 1992 Aug; 90(2):281-8. PubMed ID: 1631220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of fibrinolysis in limiting thrombus formation following severe microarterial trauma: an experimental study in the rabbit.
    Arnljots B; Wieslander JB; Dougan P; Salemark L
    Microsurgery; 1991; 12(5):332-9. PubMed ID: 1770862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of microvascular thrombosis with short-term infusion of human tissue-type plasminogen activator.
    Rohrich RJ; Handren J; Kersh R; Hergrueter CA; May JW
    Plast Reconstr Surg; 1996 Jul; 98(1):118-28. PubMed ID: 8657763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A.
    Ching S; Thoma A; Monkman S; Kelton JG
    Plast Reconstr Surg; 2003 Jul; 112(1):177-85. PubMed ID: 12832891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits.
    Krishnamurti C; Young GD; Barr CF; Colleton CA; Alving BM
    J Lab Clin Med; 1991 Dec; 118(6):523-30. PubMed ID: 1744501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of streptokinase and urokinase on microarterial thrombosis and haemostasis. An experimental study in rabbits.
    Arnljots B; Dougan P; Salemark L; Bergqvist D
    Scand J Plast Reconstr Surg Hand Surg; 1994 Mar; 28(1):9-13. PubMed ID: 8029659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintaining long-term vessel patency in microvascular surgery using tissue-type plasminogen activator.
    Romano JE; Biel MA
    Otolaryngol Head Neck Surg; 1991 Sep; 105(3):391-5. PubMed ID: 1945424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time measurement of lysis of mural platelet deposits by fibrinolytic agents under arterial flow.
    Graham DA; Huang TC; Keyt BA; Alevriadou BR
    Ann Biomed Eng; 1998; 26(4):712-24. PubMed ID: 9662163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.
    Collen D; Stassen JM; De Cock F
    Thromb Haemost; 1987 Oct; 58(3):943-6. PubMed ID: 3124288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury.
    Matsuno H; Kozawa O; Niwa M; Ueshima S; Matsuo O; Collen D; Uematsu T
    Thromb Haemost; 1999 Apr; 81(4):601-4. PubMed ID: 10235447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets and endothelial cells act in concert to delay thrombolysis--evidence from an in vitro model of the human occlusive thrombus.
    Hantgan RR; Jerome WG; Handt S
    Thromb Haemost; 1998 Mar; 79(3):602-8. PubMed ID: 9531049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the bleeding potential of vampire bat salivary plasminogen activator versus tissue plasminogen activator in an experimental rabbit model.
    Montoney M; Gardell SJ; Marder VJ
    Circulation; 1995 Mar; 91(5):1540-4. PubMed ID: 7867196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activator.
    Stassen JM; Juhan-Vague I; Alessi MC; De Cock F; Collen D
    Thromb Haemost; 1987 Oct; 58(3):947-50. PubMed ID: 2829381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyethyl starch increases patency and reduces thrombus formation following arteriotomy/intimectomy in small arteries: an experimental study in the rabbit.
    Wieslander JB; Salemark L; Dougan P
    J Reconstr Microsurg; 1990 Oct; 6(4):357-61. PubMed ID: 1702837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.
    Colucci M; Paramo JA; Stassen JM; Collen D
    J Clin Invest; 1986 Jul; 78(1):138-44. PubMed ID: 3088040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse.
    Larsson P; Alwis I; Niego B; Sashindranath M; Fogelstrand P; Wu MC; Glise L; Magnusson M; Daglas M; Bergh N; Jackson SP; Medcalf RL; Jern S
    J Thromb Haemost; 2016 Dec; 14(12):2496-2508. PubMed ID: 27706906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human recombinant tissue type plasminogen activator and its effect on microvascular thrombosis in the rabbit.
    Hergrueter CA; Handren J; Kersh R; May JW
    Plast Reconstr Surg; 1988 Mar; 81(3):418-24. PubMed ID: 3124145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of dextran and saline solution upon platelet behavior after microarterial anastomosis.
    Wieslander JB; Dougan P; Stjernquist U; Aberg M; Bergentz SE
    Surg Gynecol Obstet; 1986 Sep; 163(3):256-62. PubMed ID: 2428121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 393.